One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
For Head and Neck Cancer, It Is Still Cisplatin, But How Much, How Often, and How Tolerable? New Randomized Phase III Data For the Adjuvant Setting.
Hayes, D. Neil MPH, MD 1,,; Gleysteen, John Patrick MD 1,2,; Schwartz, David Louis MD 1,3,
doi : 10.1200/JCO.22.00274
Volume 40(18) pgs. 1967-2067 June 20, 2022
Prescriptions for Mitigating Climate Change-Related Externalities in Cancer Care: A Surgeon's Perspective.
Agbafe, Victor BA 1,; Berlin, Nicholas L. MD, MPH 2; Butler, Charles E. MD 3,; Hawk, Ernest MD, MPH 4,; Offodile II, Anaeze C. MD, MPH 3,5,,
doi : 10.1200/JCO.21.02581
Weekly Cisplatin Plus Radiation for Postoperative Head and Neck Cancer (JCOG1008): A Multicenter, Noninferiority, Phase II/III Randomized Controlled Trial.
Kiyota, Naomi MD, PhD 1,; Tahara, Makoto MD, PhD 2,,; Mizusawa, Junki ME 3,; Kodaira, Takeshi MD 4,; Fujii, Hirofumi MD 5; Yamazaki, Tomoko MD 6; Mitani, Hiroki MD 7; Iwae, Shigemichi MD 8; Fujimoto, Yasushi MD 9; Onozawa, Yusuke MD 10; Hanai, Nobuhiro MD 4,; Ogawa, Takenori MD 11; Hara, Hiroki MD 12,,; Monden, Nobuya MD 13; Shimura, Eiji MD 14; Minami, Shujiro MD 15; Fujii, Takashi MD 16; Tanaka, Kaoru MD 17,; Homma, Akihiro MD 18,; Yoshimoto, Seiichi MD 19; Oridate, Nobuhiko MD 20,; Omori, Koichi MD 21; Ueda, Tsutomu MD 22,; Okami, Kenji MD 23; Ota, Ichiro MD 24; Shiga, Kiyoto MD 25; Sugasawa, Masashi MD 26; Asakage, Takahiro MD 27; Saito, Yuki MD 28; Murono, Shigeyuki MD 29; Nishimura, Yasumasa MD 17; Nakamura, Kenichi MD 3,; Hayashi, Ryuichi MD 2,; the Head and Neck Cancer Study Group of the Japan Clinical Oncology Group (JCOG-HNCSG)
doi : 10.1200/JCO.21.01293
Trends in Late Mortality and Life Expectancy After Autologous Blood or Marrow Transplantation Over Three Decades: A BMTSS Report.
Bhatia, Smita MD, MPH 1,,; Dai, Chen MS 1; Landier, Wendy PhD 1,; Hageman, Lindsey MPH 1; Wu, Jessica MPH 1; Schlichting, Elizabeth MBA 1; Siler, Arianna BA 1; Funk, Erin BA 1; Hicks, Jessica BS 1; Lim, Shawn BS 1; Balas, Nora MSPH 1; Bosworth, Alysia BA 2; Te, Hok Sreng BA 3; Francisco, Liton BS 1; Bhatia, Ravi MD 4; Salzman, Donna MD 4; Goldman, Frederick D. MD 5; Forman, Stephen J. MD 2,; Weisdorf, Daniel J. MD 3,; Wong, F. Lennie PhD 2; Armenian, Saro H. DO, MPH 2; Arora, Mukta MD, MS 3,
doi : 10.1200/JCO.21.02372
Prophylactic Use of Compression Sleeves Reduces the Incidence of Arm Swelling in Women at High Risk of Breast Cancer-Related Lymphedema: A Randomized Controlled Trial.
Paramanandam, Vincent S. PhD 1,2,; Dylke, Elizabeth PhD 1; Clark, Gary M. PhD 3,; Daptardar, Anuradha A. BSc 2; Kulkarni, Ajeeta M. MSc, BSc 2; Nair, Nita S. DNB (Gen Surg), MRCS (Ed), MCh (Surg Onco) 2; Badwe, Rajendra A. MBBS, MS 2; Kilbreath, Sharon L. BScPT, MCISci, PhD 1,
doi : 10.1200/JCO.21.02567
Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients With Nonmetastatic Muscle-Invasive Bladder Cancer: Results of the GETUG-AFU V05 VESPER Trial.
Pfister, Christian MD, PhD 1,2,; Gravis, Gwenaelle MD 3,; Flechon, Aude MD 4,; Chevreau, Christine MD 5,; Mahammedi, Hakim MD 6,; Laguerre, Brigitte MD 7,; Guillot, Aline MD 8; Joly, Florence MD, PhD 9,; Soulie, Michel MD, PhD 10; Allory, Yves MD, PhD 11,; Harter, Valentin MSc 12; Culine, Stephane MD, PhD 13,; for the VESPER Trial Investigators
doi : 10.1200/JCO.21.02051
Sorafenib in Combination With Standard Chemotherapy for Children With High Allelic Ratio FLT3/ITD+ Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML1031.
Pollard, Jessica A. MD 1,2,,; Alonzo, Todd A. PhD 3; Gerbing, Robert MA 4; Brown, Patrick MD 5,; Fox, Elizabeth MD 6; Choi, John MD, PhD 7; Fisher, Brian DO, MSCE 8,; Hirsch, Betsy PhD 9; Kahwash, Samir MD 10; Getz, Kelly PhD 11; Levine, John MD 12,; Brodersen, Lisa Eidenschink PhD 13,; Loken, Michael R. PhD 13,; Raimondi, Susana PhD 6; Tarlock, Katherine MD 14,15; Wood, Andrew MD 16,; Sung, Lillian MD, PhD 17,; Kolb, E. Anders MD 18,; Gamis, Alan MD 19,; Meshinchi, Soheil MD, PhD 14,15; Aplenc, Richard MD, PhD 8,
doi : 10.1200/JCO.21.01612
TRACEBACK: Testing of Historical Tubo-Ovarian Cancer Patients for Hereditary Risk Genes as a Cancer Prevention Strategy in Family Members.
Delahunty, Rachel MD 1,2; Nguyen, Linh PhD 1,2; Craig, Stuart BSc(Hons) 1; Creighton, Belinda GDip 3,; Ariyaratne, Dinuka BSc(Hons) 1,; Garsed, Dale W. PhD 1,2; Christie, Elizabeth PhD 1,2,; Fereday, Sian BSc(Hons) 1,2,; Andrews, Lesley MMed 4,5; Lewis, Alexandra GDip 6; Limb, Sharne MGenCouns 2,6; Pandey, Ahwan MSc 1; Hendley, Joy 1; Traficante, Nadia BSc(Hons) 1,2,; Carvajal, Natalia MBiotech 1; Spurdle, Amanda B. PhD 7; Thompson, Bryony PhD 8,9,; Parsons, Michael T. BSc(Hons) 7; Beshay, Victoria PhD 1; Volcheck, Mila MD 1,10,11; Semple, Timothy BSc(Hons) 1; Lupat, Richard MPhil 1; Doig, Kenneth PhD 1,2,; Yu, Jiaan MSc 1; Chen, Xiao Qing MBBS 7; Marsh, Anna BSc(Hons) 7; Love, Christopher PhD 1,; Bilic, Sanela BSc 12; Beilin, Maria BSc(Hons) 12; Nichols, Cassandra B. GDip 13; Greer, Christina MGenCouns 13; Lee, Yeh Chen 4,5,14,; Gerty, Susan BSc(Hons) 4; Gill, Lynette RN 4; Newton, Emma MPH 4; Howard, Julie BNurs 4; Williams, Rachel GDip 14,15,; Norris, Christie MPH 4; Stephens, Andrew N. PhD 16,17,18,; Tutty, Erin MGenCouns 6; Smyth, Courtney GDip 19; O'Connell, Shona GDip 19; Jobling, Thomas MD 20; Stewart, Colin J.R. MD 21; Tan, Adeline MD 22,; Fox, Stephen B. DPhil 1,2,; Pachter, Nicholas 13,23,24; Li, Jason PhD 1,2; Ellul, Jason BMaCompSc(Hons) 1,2; Mir Arnau, Gisela PhD 1,2; Young, Mary-Anne MHSc 25,; Gordon, Louisa PhD 7,26; Forrest, Laura PhD 1,2; Harris, Marion MD 20; Livingstone, Karen 27; Hill, Jane 3,; Chenevix-Trench, Georgia PhD 7; Cohen, Paul A. MD 12,28,; Webb, Penelope M. PhD 7,; Friedlander, Michael MD 4,5,13,; James, Paul MD 1,2; Bowtell, David PhD 1,2,; Alsop, Kathryn PhD 1,2,,; on behalf of The Australian Ovarian Cancer Study, Ovarian Cancer Prognosis and Lifestyle Study and the TRACEBACK Study
doi : 10.1200/JCO.21.02108
Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP Study.
Bridgewater, John MD, PhD 1,,; Fletcher, Peter MSc 2; Palmer, Daniel H. MD, PhD 3,; Malik, Hassan Z. MD 4; Prasad, Raj MD 5; Mirza, Darius MD 6,; Anthony, Alan MD 5; Corrie, Pippa MD, PhD 7,; Falk, Stephen MD 8,; Finch-Jones, Meg MD 8; Wasan, Harpreet MD 9,; Ross, Paul MD 10,; Wall, Lucy MD 11,; Wadsley, Jonathan MD 12,; Evans, Thomas R. MD, PhD 13,; Stocken, Deborah PhD 14,; Stubbs, Clive MSc 2; Praseedom, Raaj MD 15; Ma, Yuk Ting MD, PhD 16,; Davidson, Brian MD 17; Neoptolemos, John MD 18,; Iveson, Tim MD 19,; Cunningham, David MD 20,; Garden, O. James MD 21; Valle, Juan W. MD 22,; Primrose, John MD 23; on behalf of the BILCAP study group
doi : 10.1200/JCO.21.02568
Pediatric Acute Myeloid Leukemia Enters the Molecularly Targeted Era Via FLT3 Inhibition.
Perl, Alexander E. MD 1,,
doi : 10.1200/JCO.22.00499
Is Dose-Adjusted EPOCH-R Less Effective in Children Than Adults With Primary Mediastinal B-Cell Lymphoma?.
Lakhotia, Rahul MBBS; Melani, Christopher MD; Roschewski, Mark MD; Wilson, Wyndham H. MD, PhD
doi : 10.1200/JCO.21.02593
Reply to R. Lakhotia et al.
Burke, G.A. Amos MBChB, PhD; Minard-Colin, Veronique MD, PhD; Auperin, Anne MD, PhD; Alexander, Sarah MD; Pillon, Marta MD, PhD; Delgado, Rafael MD, PhD; Zsiros, Jozsef MD, PhD; Uyttebroeck, Anne MD, PhD; Dartigues, Peggy MD; Miles, Rodney R. MD, PhD; Kazanowska, Bernarda MD, PhD; Chiang, Alan K. MD, PhD; Haouy, Stephanie MD; Bollard, Catherine M. MBChB, MD; Csoka, Monika MD, PhD; Wheatley, Keith PhD; Barkauskas, Donald A. PhD; Adamson, Peter C. MD; Vassal, Gilles MD, PhD; Patte, Catherine MD; Gross, Thomas G. MD, PhD
doi : 10.1200/JCO.21.02912
Antibody-Drug Conjugates as an Adjuvant Therapy for Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer.
Asazuma, Kazuki MD; Shimomura, Akihiko MD, PhD; Shimizu, Chikako MD, PhD
doi : 10.1200/JCO.22.00135
